Advances in adult and pediatric asthma

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

卷:113

Article

Apter, AJ ; Szefler, SJ

关键词: asthma;    adult asthma;    pediatric asthma;    adherence;    disease management;    epidemiology;    drug therapy;    medical economics;    atopy;    minorities;    inhaled corticosteroids;    health disparities;    guidelines;    alletgic bronchopulmonary aspergillosis;    omalizumab;    montelukast;    clinical research;   

DOI  :  10.1016/j.jaci.2003.12.002

来源: Elsevier

【 摘 要 】

This review summarizes the highlights in the study of adult and pediatric asthma from October 2002 through October 2003. It is easiest to categorize this year's advances into physiologic, epidemiologic, therapeutic, and primarily pediatric developments. In physiology the identification of the ADAM33 gene as an asthma susceptibility gene has led to a new hypothesis concerning the pathogenesis of asthma. Understanding the integration of the upper and lower airways is likely to have important implications for patient management. Epidemiologic studies continue to show that asthma is a significant and costly disease, with medications comprising the most significant direct costs. Early intervention and improved management can significantly reduce the burden of illness. Research presented indicates there is an opportunity for allergist-immunologists to improve diagnostic and therapeutic approaches to asthma management. Our community has a strong commitment to health care quality, education, and delivery. The Journal will reflect this commitment with a new section devoted to these issues.

【 授权许可】

Free